AVXL
AVXL
NASDAQ · Biotechnology

Anavex Life Sciences Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.34
+0.06 (+1.83%)
As of Aug 8, 10:25 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +793.7% upside
Low Target $17.55
Average Target $29.85
High Target $40.51
Current Price $3.34
Current
$3.34
Target
$29.85
$17.55 $29.85 avg $40.51
Scenario Analysis
Bear Case
$17.55
425.4%
Low target
Base Case
$29.85
+793.7%
Avg target
Bull Case
$40.51
+1,112.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$11.70
-71.5% from high
52-Week Low
$2.26
+48.1% from low
Target vs 52W High
$29.85
+155.1% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.08
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%